(2R,5R,7R,8R,10R,12aR,14R,15R,15aS,16R)-7,14-Bis(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide
- Catalog No. :
- ACULMK531
- CAS No. :
- 1638241-89-0
- Molecular Formula :
- C20H24N10O10P2S2
- Molecular Weight :
- 690.55
IUPAC Name:(2R,5R,7R,8R,10R,12aR,14R,15R,15aS)-7,14-bis(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$495.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (2R,5R,7R,8R,10R,12aR,14R,15R,15aS,16R)-7,14-Bis(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide |
|---|---|
| IUPAC Name | (2R,5R,7R,8R,10R,12aR,14R,15R,15aS)-7,14-bis(6-amino-9H-purin-9-yl)-15,16-dihydroxy-2,10-dimercaptooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecine 2,10-dioxide |
| MDL No. | MFCD28900737 |
| Molecular Formula | C20H24N10O10P2S2 |
| Molecular Weight | 690.55 |
| SMILES | OC1([H])[C@](O[P@](S)(OC[C@](O[C@@H](N2C3=NC=NC(N)=C3N=C2)[C@@H]4O)([H])[C@@]4([H])O5)=O)([H])[C@H](N6C7=NC=NC(N)=C7N=C6)O[C@]1([H])CO[P@]5(S)=O |
| InChI Key | IZJJFUQKKZFVLH-OGJYVCTBSA-N |
| Synonym | ML RR-S2 CDA;STING-INDUCER-1;1638241-89-0;STING-Inducer-1;ML RR-S2 CDA;Adenosine, [P(R)]-5'-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(2'→5')-, cyclic nucleotide;MIW815;ML RR-S2 CDA;MIW815;STING-INDUCER-1;ADUS100,ADU S100,ADU-S-100;ML RR-S2 CDA(MIW815 |
| CAS No. | 1638241-89-0 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338

